ClinicalTrials.Veeva

Menu

Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Thyroid Cancer

Treatments

Drug: normal saline infusion
Drug: Systemic intravenous lidocaine infusion

Study type

Interventional

Funder types

Other

Identifiers

NCT01907997
4-2013-0342

Details and patient eligibility

About

Systemic lidocaine infusion may improve the patients' recovery quality and chronic post surgical pain after robot-assisted thyroidectomy

Enrollment

90 patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 20-65
  • ASA class I and II
  • Thyroid cancer patients who are scheduled for elective robot-assisted thyroidectomy

Exclusion criteria

  • Allergy to local anesthetics or contraindication to use of lidocaine
  • Pregnancy
  • Severe cardiovascular disease
  • Renal failure
  • Liver failure
  • Neurologic and psychologic disease
  • Chronic treatment with analgesics

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 2 patient groups, including a placebo group

Group L
Experimental group
Description:
Intravenous lidocaine infusion group
Treatment:
Drug: Systemic intravenous lidocaine infusion
Group C
Placebo Comparator group
Description:
Intravenous normal saline infusion - control group
Treatment:
Drug: normal saline infusion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems